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INTRODUCTION
Carpal tunnel syndrome (CTS) is the most common peripheral 
nerve compression syndrome, and non-inflammatory fibrosis 
and thickening of the subsynovial connective tissue (SSCT) are 
common pathologic findings in CTS.1-4 SSCT is an important 
and unique structure, similar to the paratenon, which sur-
rounds the flexor tendons and median nerve in the carpal tun-
nel comprising all tissues between the visceral synovial sheath 
and the flexor tendons.2,5 SSCT is composed of multiple layers 
of collagen bundles that run parallel to the flexor tendons, which 
are interconnected by vertical fibers.6 Fibrosis of SSCT is pro-
nounced next to the flexor tendons, suggesting that shear forces 
between the tendons and SSCT are associated with pathologic 
changes.7,8 Excessive and repetitive shear forces are thought to 
initiate a series of mechanical events, such as altered stiffness 
and SSCT permeability, increased volume of the carpal tunnel 
contents,6,9 elevated pressure,10 ischemia,11 and compression of 
the median nerve. In CTS patients, increased adherence or dis-
sociation between the flexor tendons and SSCT may increase 
shear forces even further.12 These shear forces could induce fi-
brosis of SSCT, which hampers median nerve mobility in CTS 
patients.5,10,13 Increased shear modulus and pull-out force are 
also reported at the tissue level in SSCT from CTS patients.12,14
Fibrosis of SSCT is associated with an increase in transform-
ing growth factor beta (TGF-β) activity, which can up-regulate 
both fibroblast proliferation and activation.2,15 TGF-β stimulates 
membrane-cytoskeletal structural protein formation, which 
mechanically generates and transmits contractile force to the 
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extracellular matrix (ECM).2,15 TGF-β is also implicated in the 
synthesis of ECM through multiple signal transduction path-
ways.16 In addition, TGF-β exerts ECM-preserving actions by 
suppressing the activity of matrix metalloproteinases (MMPs) 
and also by inducing synthesis of protease inhibitors, such as 
plasminogen activator inhibitor-1 and tissue inhibitor of metal-
loproteinase (TIMP).17
Relaxin (RLN), a member of the insulin superfamily, is a sub-
stance that influences the reproductive tract.18 RLN inhibits fi-
brosis and inflammatory activities at multiple levels, through 
activation of G-protein-coupled receptor, and also inhibits in-
flammatory cell influx and ameliorates the effects of profibrotic 
factors, such as TGF-β, injured organs.19
The anti-fibrogenic effect of RLN20 might provide a therapeu-
tic target for the treatment of CTS, via the interwoven pathways 
of MMPs, TIMPs, collagenesis, and collagenolysis. With proven 
efficacy at the molecular level, RLN therapy might prevent the 
progression of SSCT fibrosis, or even resolve fibrosis, using a 
minimally invasive injection, depending on the stage of CTS. 
Therefore, this study aimed to investigate the anti-fibrotic effect 
of RLN, activated by TGF-β1, on subsynovial fibroblast of CTS 
patients.
MATERIALS AND METHODS
The Human Subjects Institutional Review Board approved all of 
the experimental protocols in this study.
Study design
To test the anti-fibrotic effect of the adenovirus-relaxin con-
struct (Ad-RLN) on synovial fibroblasts in vitro, we utilized cells 
from the tissues of patients with CTS. Synovial fibroblasts were 
activated by TGF-β1 (2 ng/mL), exposed to Ad-RLN as a thera-
peutic gene and adenovirus-lacZ construct (Ad-LacZ) as a 
marker gene, and cultured for four hours. Synovial fibroblast 
cultures, without adenoviral exposure, served as the control. 
The mRNA expression levels of collagen types I, III, IV, V, and XI, 
as well as MMP-1, -3, -8, -9, and -13 were analyzed by reverse-
transcription polymerase chain reaction. In addition, protein 
expression levels of fibronectin, phosphorylation of Smad2 and 
ERK1/2, and alpha smooth muscle actin (α-SMA) were esti-
mated using western blot analysis. Finally, total collagen syn-
thesis was assayed.
Isolation and culture of cells
The SSCT were harvested from seven patients with CTS during 
open carpal tunnel release. Minced tissues were digested at 
37°C under gentle agitation with type IV collagenase (250 unit/
mL; Sigma, St. Louis, MO, USA). Cells were placed in culture 
plates (TPP®, Trasadingen, Switzerland) at 4×105 cells/mL. Pri-
mary cultures were sustained for two to three weeks in Dulbec-
co’s Modified Eagle Medium (Life Technologies Corporation) 
containing 10% fetal bovine serum, 1% v/v penicillin, strepto-
mycin, and nystatin (Life Technologies Corporation), in a 37°C 
incubator with 5% CO2 and humidity.
Relaxin constructs and transfections
For this study, Ad-LacZ expressing the lacZ gene was used as a 
viral control, and Ad-RLN expressing the human RLN gene was 
also prepared. Each recombinant adenoviral vector originated 
from replication-deficient adenovirus type 5 lacking E1 and E3 
regions. The RLN gene was cloned into the E1 region under the 
control of the human cytomegalovirus early promoter.21 Re-
combinant virus was grown in transformed human embryonic 
kidney 293 cells and purified with VIVAPURE ADENOPACK 
100 (Sartorius Stedim biotech, Goettingen, Germany). Titers 
were determined by optical density at 260 nm.21 At confluence, 
the subsynovial fibroblastic cells were rinsed with Dulbecco’s 
Phosphate Buffered Saline (Life Technologies Corporation), and 
then exposed to Dulbecco’s Modified Eagle Medium (DMEM) 
containing one dose of Ad-LacZ or Ad-RLN with a viral concen-
tration of 80 multiplicity of infection.
Reverse-transcription polymerase chain reaction 
analysis for matrix metalloproteinases and collagens
Total RNA was isolated from the subsynovial fibroblasts trans-
fected with Ad-RLN, using the QIAGEN RNeasy® mini kit (QIA-
GEN, Germantown, MD, USA). In addition, cDNA was pre-
pared using the QuantiTect® Reverse Transcription Kit (QIAGEN, 
CA, USA). Collagen and MMP genes were amplified, while rela-
tive expressions were normalized to the average beta-actin lev-
els. Resulting data were analyzed using the ImageJ software, 
Ver. 1.6 (National Institutes of Health, Bethesda, MD, USA).
Protein extraction and western blot analysis
Cells (2×105 per well) were transfected with Ad-RLN for four 
hours, and lysed in RIPA lysis buffer (ATTO Corp., Tokyo, Japan) 
containing protease inhibitor (Pierce, Rockford, IL, USA). Mean-
while, the culture medium was analysed for RLN protein ex-
pression by Ad-RLN. Lysates and culture medium were resolved 
on sodium dodecyl sulfate-polyacrylamide gel electrophoresis, 
and proteins were then transferred to polyvinylidenedifluoride 
(Pierce) membranes using a transfer system (Mini Trans-Blot® 
Cell and systems, Bio-Rad, Hercules, CA, USA). The blots were 
incubated with specific antibodies against MMP-1, MMP-13 
(Young In Frontier Co., Ltd., Seoul, Korea), ERK1/2, phosphor-
ERK1/2 Smad2, phosphor-Smad2 (Cell Signaling Technology, 
Danvers, MA, USA), beta galactosidase, α-SMA, fibronectin, 
TIMP 1, and TIMP 4 (Abcam®, Cambridge, UK). After reacting 
with secondary antibodies, immunoreactive bands were visual-
ized by a western blot detection system (ATTO Corp.). To verify 
the amounts of loaded proteins, blots were stripped of bound 
antibodies and re-probed using antibodies to actin (Abcam®).
417
Young-Mi Kang, et al.
https://doi.org/10.3349/ymj.2017.58.2.415
Total collagen content assay
In the DMEM medium, cells transfected with Ad-RLN were 
grown at a density of 4×104 cells per well on 35-mm culture 
plates for four hours. Collagen was harvested from these cells, 
after lysing them in a buffer containing 0.5 M acetic acid and 
protease inhibitors. The collagen samples were concentrated 
according to an isolation and concentration protocol, and the 
amount was then measured spectrophotometrically at 555 nm 
(Biocolor LTD., Carrickfergus, UK). 
Statistical analyses
All data are expressed as mean±standard deviation (SD), com-
piled from three independent experiments of separate cultures 
isolated from seven donors. Two-tailed Student’s t-test was 
used to compare the means of the two groups. In our analyses, 
a value of p<0.05 was considered statistically significant.
RESULTS
Beta galactosidase and relaxin expression 
in synovial fibroblasts
Western blot analysis of beta-galactosidase and RLN protein 
expressions in subsynovial fibroblasts from CTS patients trans-
fected with either Ad-LacZ or Ad-RLN indicated a highly effi-
cient transduction rate for the adenoviral marker gene con-
struct (Fig. 1).
mRNA expression of collagen and matrix 
metalloproteinase
The mRNA expressions of collagen types I and III in the subsy-
novial fibroblasts of CTS patients transfected with Ad-RLN de-
creased by 60% and 20%, respectively, compared to the control 
culture with TGF-β1 and Ad-LacZ (*:p<0.05, †: p<0.001), where-
as that of collagen type IV increased 30%, compared to the con-
trol culture with TGF-β1 and Ad-LacZ (p<0.05) (Fig. 2). On the 
other hand, however, no significant difference was found in the 
expressions of collagen type V, at mRNA level (*: p<0.05, †: 
p<0.001).
Furthermore, at the four-hour mark, subsynovial fibroblasts 
from CTS patients transfected with Ad-RLN showed increases of 
30, 10, 80, and 40% in MMP-1, -3, -8, and -9 mRNA expressions, 
respectively, compared to the control culture with TGF-β1 and 
Ad-LacZ (*: p<0.05, †: p<0.001) (Fig. 3).
Expressions of Smad2 and ERK1/2
Subsynovial fibroblasts from CTS patients with Ad-RLN showed 
a 60% increase in the level of phospho-ERK1/2 protein expres-
sion after four hours, compared to cells cultured with TGF-β1 
and Ad-LacZ (p<0.05). Meanwhile, phospho-Smad2 protein 
expression showed a 60% decrease under identical condition to 
the above (p<0.001) (Fig. 4).
TIMP 1 and TIMP 4 expressions
Subsynovial fibroblasts from CTS patients with Ad-RLN showed 
a 45% decrease in TIMP 1 expression and a 55% decrease in 
TIMP 4 expression after four hours, compared to the control 
culture with TGF-β1 and Ad-LacZ (p<0.001) (Fig. 5).
Expressions of Alpha-Smooth Muscle Actin (α-SMA) 
and fibronectin
Subsynovial fibroblasts from CTS patients transfected with Ad-
RLN showed a 60% decrease in the level of α-SMA expression at 
four hours, compared to cells cultured with TGF-β1 and trans-
fected with Ad-LacZ (p<0.05). Fibronectin protein expression in 
the Ad-RLN transfected cells decreased by 40%, compared to 
cells cultured with TGF-β1 and Ad-LacZ (p<0.001) (Fig. 6).
Total collagen content
Subsynovial fibroblasts from CTS patients transfected with Ad-
RLN showed a 15% increase in total collagen protein expression 
at four hours, compared to the control culture with TGF-β1 and 
Ad-LacZ (*: p<0.05, †: p<0.001) (Fig. 7).
DISCUSSION
The SSCT, a net-like connective tissue, connects the finger flex-
or tendons and median nerve and acts as a sliding unit to de-
crease friction during finger movement.4,22 A non-inflammatory 
fibrotic change and thickening of the SSCT are known to initi-
ate an elevation of pressure in the carpal tunnel, causing neu-
ropathy in idiopathic CTS.2,4,22 In recent studies, synovial edema 
and synovial vascular proliferation were observed in patients 
with CTS.23 Myofibroblast and collagen type IV expression were 
detected in patients with idiopathic CTS, both of which are in-
volved in the fibrotic process without relevance of inflamma-
tion.24 The exact mechanisms of SSCT fibrosis are unknown, al-
though fibrosis in SSCT is a common histologic finding in 
idiopathic CTS.2,24 Furthermore, general consensussuggest that 
collagenous structure is changed by continuous exposure to 
Fig. 1. Subsynovial fibroblasts from patients with carpal tunnel syndrome 
were transfected with Ad-RLN and Ad-LacZ. The expressions of beta-ga-
lactosidase and relaxin compared to cells transfected with control with 
TGF-β1 or treated with SB505124, a TGF-β inhibitor, indicate a highly effi-
cient transduction rate for the adenoviral construct. TGF-β1, transforming 
growth factor beta 1; Ad-RLN, adenovirus-relaxin gene construct; Ad-
LacZ, adenovirus LacZ gene construct.
β-gal Relaxin
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shear stress,25 which induces overexpression in collagens and 
ECM components, and results in overall volume reduction and 
compression of the median nerve.23 Also, increase of collagen 
type IV in SSCT refers to accretion in the basal lamina, which 
leads to vascular proliferation and fibrosis.26 In addition, in-
creased stiffness in human SSCT may cause fibroblast to trans-
form into myofibroblast. In CTS animal model, overexpression 
of TGF-β1 and connective tissue growth factor (CTGF) were 
identified in the SSCT with shear injury.27
Normally, both expression and suppression of TGF-β1 and 
CTGF are found in the course of wound healing.28 However, re-
petitive injury promotes fibrosis in tissue and ECM, as well as 
profibrotic growth factor such as TGF-β1.29 TGF-β1 stimulates 
fibroblast, accumulates ECM, and downregulates MMPs and 
collagenases,30 resulting in a vicious circle of TGF-β1 that initi-
ates fibrotic signaling, including increased matrix deposition.27 
Many previous studies showed that the expressions of TGF-β 
and its receptors increased with SSCT fibrosis in CTS.2,27,31 In ad-
dition, SSCT fibrosis is marked by the following events: increased 
activation of canonical TGF-β second messenger Smads,31,32 in-
creased expression of downstream fibrotic mediators such as 
CTGF,27,31 increased production of collagen types I, III, and IV,2,31,33 
and decreased expression of matrix metalloproteases.15,31,33
When conservative treatment fails to relieve the patient’s 
symptoms of CTS, surgical decompression of the median nerve 
is usually indicated.34 Although release of the median nerve is a 
simple and effective procedure, complications such as wound 
infection, scar and pillar area pain, injuries to the nerve and 
flexor tendons, and rarely incomplete release have been report-
ed. If an alternative effective non-operative local treatment is 
available, it should be considered for this compressive neurop-
athy.
RLN acts also as an antagonist for fibrosis, and promotes 
wound-healing, neo-angiogenesis, and vasodilation.19,35,36 It also 
Fig. 2. Collagen mRNA expression in fibroblasts from patients with carpal tunnel syndrome transfected with Ad-RLNs. Collagen type I, III, and IV expres-
sions were decreased in the cells transfected with Ad-RLN compared to control with TGF-β1 and Ad-LacZ. *p<0.05, †p<0.001. TGF-β1, transforming 
growth factor beta 1; Ad-RLN, adenovirus-relaxin gene construct; Ad-LacZ, adenovirus LacZ gene construct.
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affects both contraction and relaxation of ligaments around the 
pelvis for the maintenance of pregnancy and parturition.18,37 
RLN has been shown to promote matrix remodeling by increas-
ing cell proliferation, reducing α-SMA expression, and decreasing 
collagen synthesis in renal fibroblasts.38 Furthermore, recombi-
nant human RLN can alter the connective tissue phenotype of 
human lung fibroblast, decrease overexpression of procollagen 
type I and III induced by TGF-β1, and reduce both synthesis 
and secretion of MMP-1.39 When exposed to RLN, human der-
mal fibroblasts can modulate secretion of MMPs and collage-
nase inhibitors.40 It has earlier been suggested that the RLN 
gene renders antifibrogenic effects on myofibroblastic cells 
from Dupuytren’s nodule via a direct inhibition of collagen syn-
thesis, not through a collagenolytic pathway, such as MMP-1 or 
-13 and TIMP 1 or 3.20
In the present study, we transformed subsynovial fibroblast 
to myofibroblast with TGF-β1, and investigated the effects of 
RLN on anti-fibrosis using genetic modification of subsynovial 
fibroblastic cells from patients with CTS using Ad-RLN. The 
mRNA expression levels of MMPs significantly increased after 
RLN transgene expression. In particular, the expression levels 
of MMP-1, -3, -8, and -9 increased, whereas the protein expres-
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Fig. 3. mRNA expressions of matrix metalloproteinases in subsynovial fibroblasts from patients with carpal tunnel syndrome transfected with Ad-RLN. 
MMP-1, -3, -8, -9, and -13 expressions increased in the cells transfected with Ad-RLN compared to control with TGF-β1 and Ad-LacZ. *p<0.05, †p<0.001. 
TGF-β1, transforming growth factor beta 1; Ad-RLN, adenovirus-relaxin gene construct; Ad-LacZ, adenovirus LacZ gene construct.
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sion levels of TIMP 1 and TIMP 4 decreased by approximately 
45% and 55%, respectively, compared to the control culture 
with TGF-β1 and Ad-LacZ. In particular, the synthesis of colla-
gen type IV, a marker associated with vascular wall thickness, 
was reduced by RLN, implying that RLN can inhibit vascular 
proliferation. These observations suggest that RLN can act on 
the process of collagenolysis, in addition to the synthesisof col-
lagen, and that RLN gene can influence both collagenesis as 
well as collagenolysis in CTS patients. In addition, RLN de-
creased α-SMA expression by 60% and fibronectin expression 
by 45%, both of which are the main components of ECM. Also, 
RLN decreased phosphorylation of Smad by approximately 
60%. Therefore, a possibility exists that RLN can block the TGF-
β1-Smad-ERK pathway.
There are a few limitations on this study: 1) we did not assess 
whether RLN affected subsynovial fibroblast without TGF-β1. 2) 
We did not confirm basal TGF-β1 expression in the tissue. Last-
ly, 3) we did not evaluate whether RLN acted on the individual 
fibroblast from CTS and dupuytren disease through the same 
mechanism involved in anti-fibrosis.
In conclusion, RLN prevents excessive synthesis of ECM by 
reducing expressions of its components, such as fibronectin, 
α-SMA, and phosphorylated Smad2, by increasing expression 
of MMPs; and by decreasing expression of TIMPs. Neverthe-
less, additional studies on subsynovial fibroblasts are neces-
sary, since RLN can act in a complicated manner. Moreover, in-
depth investigation on RLN behavior in ECM remodeling 
Fig. 5. TIMPs and MMPs protein expression in subsynovial fibroblasts 
from patients with carpal tunnel syndrome when transfected with Ad-
RLN. The expressions of TIMP 1 and TIMP 4 decreased whereas MMP-1 
expression increased in the cells transfected with Ad-RLN compared to 
control with TGF-β1 and Ad-LacZ. p<0.001. TGF-β1, transforming growth 
factor beta 1; TIMP, tissue inhibitor of metalloproteinase; MMP, matrix 
metalloproteinase; Ad-RLN, adenovirus-relaxin gene construct; Ad-LacZ, 
adenovirus LacZ gene construct.
MMP-1
MMP-13
SB505124
TIMP 4
TIMP 1
SB505124
Ad-LacZ Ad-LacZ
Ad-RLN Ad-RLN
TGF-β1 TGF-β1+  +  +  +
–  +  –  –
–  –  +  –
–  –  –  +
+  +  +  +
–  +  –  –
–  –  +  –
–  –  –  +
Fig. 4. Phospho-ERK and phospho-Smad2 protein expressions in subsy-
novial fibroblasts from patients with carpal tunnel syndrome when trans-
fected with Ad-RLN. ERK1/2 and Smad2 phosphorylation decreased in 
the cells transfected with Ad-RLN compared to control with TGF-β1 and 
Ad-LacZ. p<0.001. TGF-β1, transforming growth factor beta 1; Ad-RLN, 
adenovirus-relaxin gene construct; Ad-LacZ, adenovirus LacZ gene con-
struct.
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Fig. 6. Alpha smooth muscle actin and fibronectin protein expression in 
subsynovial fibroblasts from patients with carpal tunnel syndrome when 
transfected with Ad-LacZ. Alpha smooth muscle actin and fibronectin 
decreased in the cells transfected with Ad-RLN compared to control with 
TGF-β1 and Ad-LacZ. p<0.001. TGF-β1, transforming growth factor beta 1; 
RLN, relaxin; α-SMA, alpha smooth muscle actin; Ad-RLN, adenovirus-
relaxin gene construct; Ad-LacZ, adenovirus LacZ gene construct.
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should be continued.
ACKNOWLEDGEMENTS
We would like to thank Chae-Ok Yun, Ph.D. (Department of 
Bioengineering, College of Engineering, Hanyang University, 
Seoul, Korea) for providing the adenovirus-relaxin construct. 
This work was supported, in part, by the Brain Korea 21 PLUS 
Project for Medical Science at Yonsei University.
This study was supported by a faculty research program from 
Yonsei University College of Medicine (6-2014-0098), as well as 
the Basic Science Research Program through the National Re-
search Foundation of Korea funded by the Ministry of Science, 
ICT & Future Planning (grant number: 2011-0014399).
REFERENCES
1. Armstrong TJ, Castelli WA, Evans FG, Diaz-Perez R. Some histo-
logical changes in carpal tunnel contents and their biomechani-
cal implications. J Occup Med 1984;26:197-201.
2. Ettema AM, Amadio PC, Zhao C, Wold LE, An KN. A histological 
and immunohistochemical study of the subsynovial connective 
tissue in idiopathic carpal tunnel syndrome. J Bone Joint Surg Am 
2004;86-A:1458-66.
3. Nakamichi K, Tachibana S. Histology of the transverse carpal liga-
ment and flexor tenosynovium in idiopathic carpal tunnel syn-
drome. J Hand Surg Am 1998;23:1015-24.
4. Neal NC, McManners J, Stirling GA. Pathology of the flexor ten-
don sheath in the spontaneous carpal tunnel syndrome. J Hand 
Surg Br 1987;12:229-32.
5. Oh J, Zhao C, Amadio PC, An KN, Zobitz ME, Wold LE. Immuno-
localization of collagen types in the subsynovial connective tissue 
within the carpal tunnel in humans. J Orthop Res 2005;23:1226-31.
6. Ettema AM, Amadio PC, Zhao C, Wold LE, O’Byrne MM, Moran 
SL, et al. Changes in the functional structure of the tenosynovium 
in idiopathic carpal tunnel syndrome: a scanning electron micro-
scope study. Plast Reconstr Surg 2006;118:1413-22.
7. Schuind F, Ventura M, Pasteels JL. Idiopathic carpal tunnel syn-
drome: histologic study of flexor tendon synovium. J Hand Surg 
Am 1990;15:497-503.
8. Ettema AM, Zhao C, An KN, Amadio PC. Comparative anatomy of 
the subsynovial connective tissue in the carpal tunnel of the rat, 
rabbit, dog, baboon, and human. Hand (N Y) 2006;1:78-84.
9. Jinrok O, Zhao C, Amadio PC, An KN, Zobitz ME, Wold LE. Vascu-
lar pathologic changes in the flexor tenosynovium (subsynovial 
connective tissue) in idiopathic carpal tunnel syndrome. J Orthop 
Res 2004;22:1310-5.
10. Zhao C, Ettema AM, Berglund LJ, An KN, Amadio PC. Gliding re-
sistance of flexor tendon associated with carpal tunnel pressure: 
a biomechanical cadaver study. J Orthop Res 2011;29:58-61.
11. Keir PJ, Rempel DM. Pathomechanics of peripheral nerve loading. 
Evidence in carpal tunnel syndrome. J Hand Ther 2005;18:259-69.
12. Ettema AM, An KN, Zhao C, O’Byrne MM, Amadio PC. Flexor 
tendon and synovial gliding during simultaneous and single digit 
flexion in idiopathic carpal tunnel syndrome. J Biomech 2008;41: 
292-8.
13. Yamaguchi T, Osamura N, Zhao C, Zobitz ME, An KN, Amadio 
PC. The mechanical properties of the rabbit carpal tunnel subsy-
novial connective tissue. J Biomech 2008;41:3519-22.
14. Osamura N, Zhao C, Zobitz ME, An KN, Amadio PC. Evaluation 
of the material properties of the subsynovial connective tissue in 
carpal tunnel syndrome. Clin Biomech (Bristol, Avon) 2007;22:999-
1003.
15. Verrecchia F, Mauviel A. Transforming growth factor-beta signal-
ing through the Smad pathway: role in extracellular matrix gene 
expression and regulation. J Invest Dermatol 2002;118:211-5.
16. Gauldie J, Bonniaud P, Sime P, Ask K, Kolb M. TGF-beta, Smad3 
and the process of progressive fibrosis. Biochem Soc Trans 2007; 
35(Pt 4):661-4.
17. Mauviel A. Transforming growth factor-beta: a key mediator of fi-
brosis. Methods Mol Med 2005;117:69-80.
18. Schwabe C, Büllesbach EE. Relaxin, the relaxin-like factor and their 
receptors. Adv Exp Med Biol 2007;612:14-25.
19. Formigli L, Francini F, Nistri S, Margheri M, Luciani G, Naro F, et al. 
Skeletal myoblasts overexpressing relaxin improve differentiation 
and communication of primary murine cardiomyocyte cell cul-
tures. J Mol Cell Cardiol 2009;47:335-45.
20. Kang YM, Choi YR, Yun CO, Park JO, Suk KS, Kim HS, et al. Down-
regulation of collagen synthesis and matrix metalloproteinase ex-
pression in myofibroblasts from Dupuytren nodule using adeno-
virus-mediated relaxin gene therapy. J Orthop Res 2014;32:515-23.
21. Kim JH, Lee YS, Kim H, Huang JH, Yoon AR, Yun CO. Relaxin ex-
pression from tumor-targeting adenoviruses and its intratumoral 
spread, apoptosis induction, and efficacy. J Natl Cancer Inst 2006; 
98:1482-93.
22. Yoshii Y, Zhao C, Schmelzer JD, Low PA, An KN, Amadio PC. The 
effects of hypertonic dextrose injection on connective tissue and 
nerve conduction through the rabbit carpal tunnel. Arch Phys Med 
Rehabil 2009;90:333-9.
2.0
1.5
1.0
0.5
0.0
To
ta
l c
ol
la
ge
n/
pr
ot
ei
n
Fig. 7. Total collagen expression in subsynovial fibroblasts from patients 
with carpal tunnel syndrome when transfected with Ad-RLN. Collagen 
expression decreased in the cells transfected with Ad-RLN compared to 
control with TGF-β1 and Ad-LacZ. *p<0.05, †p<0.001. TGF-β1, transforming 
growth factor beta 1; Ad-RLN, adenovirus-relaxin gene construct; Ad-
LacZ, adenovirus LacZ gene construct.
*
†
†
SB505124
Ad-LacZ
Ad-RLN
TGF +  +  +  +
–  +  –  –
–  –  +  –
–  –  –  +
422
Control of ECM in Synovial Fibroblasts Using Relaxin Gene
https://doi.org/10.3349/ymj.2017.58.2.415
23. Tekin F, Sürmeli M, S¸ims¸ek H, Ceran C, Tezcan S, Taner ÖF, et al. 
Comparison of the histopathological findings of patients with di-
abetic and idiopathic carpal tunnel syndrome. Int Orthop 2015;39: 
2395-401.
24. Yes¸il M, Bacakaog˘lu AK, Dog˘an M. Are myofibroblasts activated 
in idiopathic carpal tunnel syndrome? an immunohistochemical 
study. Eklem Hastalik Cerrahisi 2014;25:133-40.
25. Tat J, Wilson KE, Keir PJ. Pathological changes in the subsynovial 
connective tissue increase with self-reported carpal tunnel syn-
drome symptoms. Clin Biomech (Bristol, Avon) 2015;30:360-5.
26. Hinz B. Tissue stiffness, latent TGF-beta1 activation, and mechani-
cal signal transduction: implications for the pathogenesis and 
treatment of fibrosis. Curr Rheumatol Rep 2009;11:120-6.
27. Chikenji T, Gingery A, Zhao C, Passe SM, Ozasa Y, Larson D, et al. 
Transforming growth factor-β (TGF-β) expression is increased in 
the subsynovial connective tissues of patients with idiopathic car-
pal tunnel syndrome. J Orthop Res 2014;32:116-22.
28. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. 
Growth factors and cytokines in wound healing. Wound Repair Re-
gen 2008;16:585-601. 
29. Border WA, Noble NA. Transforming growth factor beta in tissue 
fibrosis. N Engl J Med 1994;331:1286-92.
30. Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. 
FASEB J 2004;18:816-27.
31. Gingery A, Yang TH, Passe SM, An KN, Zhao C, Amadio PC. TGF-β 
signaling regulates fibrotic expression and activity in carpal tun-
nel syndrome. J Orthop Res 2014;32:1444-50.
32. Millan FA, Denhez F, Kondaiah P, Akhurst RJ. Embryonic gene ex-
pression patterns of TGF beta 1, beta 2 and beta 3 suggest different 
developmental functions in vivo. Development 1991;111:131-43.
33. Verrecchia F, Chu ML, Mauviel A. Identification of novel TGF-be-
ta /Smad gene targets in dermal fibroblasts using a combined 
cDNA microarray/promoter transactivation approach. J Biol Chem 
2001;276:17058-62.
34. Ucan H, Yagci I, Yilmaz L, Yagmurlu F, Keskin D, Bodur H. Com-
parison of splinting, splinting plus local steroid injection and open 
carpal tunnel release outcomes in idiopathic carpal tunnel syn-
drome. Rheumatol Int 2006;27:45-51.
35. Samuel CS, Lin F, Hossain MA, Zhao C, Ferraro T, Bathgate RA, et 
al. Improved chemical synthesis and demonstration of the relaxin 
receptor binding affinity and biological activity of mouse relaxin. 
Biochemistry 2007;46:5374-81.
36. van der Westhuizen ET, Halls ML, Samuel CS, Bathgate RA, Un-
emori EN, Sutton SW, et al. Relaxin family peptide receptors--from 
orphans to therapeutic targets. Drug Discov Today 2008;13:640-
51.
37. Hisaw FL. Experimental relaxation of the pubic ligament of the 
guinea pig. Proc Soc Exp Biol Med 1926;23:661-3.
38. Masterson R, Hewitson TD, Kelynack K, Martic M, Parry L, Bath-
gate R, et al. Relaxin down-regulates renal fibroblast function and 
promotes matrix remodelling in vitro. Nephrol Dial Transplant 
2004;19:544-52.
39. Unemori EN, Pickford LB, Salles AL, Piercy CE, Grove BH, Erikson 
ME, et al. Relaxin induces an extracellular matrix-degrading phe-
notype in human lung fibroblasts in vitro and inhibits lung fibrosis 
in a murine model in vivo. J Clin Invest 1996;98:2739-45.
40. Unemori EN, Amento EP. Relaxin modulates synthesis and secre-
tion of procollagenase and collagen by human dermal fibroblasts. 
J Biol Chem 1990;265:10681-5.
